Anticancer drugs
 Add to favourites!!!

Anticancer drugs






Anticancer drugs

  Abstract TEMPLATE
  Download the program as PDF






Advisory Board Member

Jalal Pourahmad, Ph.D., Pharm.D., M.Sc.,
Professor of Toxicology and Pharmacology,
Shaheed Beheshti University of Medical Sciences,
Faculty of Pharmacy
Tehran, Iran




Dr. Jalal pourahmad graduated as Doctor of Pharmacy in 1988 From Mashhad University, Iran and as Ph.D. in Toxicology in 2001 from University of Toronto, Canada. He is currently working as a Full Professor in Shahid Beheshti University of Medical Sciences, Tehran, Iran. He has so far published two books and more than 60 scientific papers in English and Farsi. He is exploring ways of decreasing the toxicity of cancer drugs and increasing their therapeutic specificity. These methods include the use of less toxic drug analogues, antidotes, improving the nutritional status of the patient and targeting of the drug to the tissue that requires therapy. The biochemical research techniques used include the monitoring of changes in biomolecules, cellular metabolism mitochondrial/lysosomal function when drugs are administered in vivo, perfused intact organs, or incubated with intact cells or subcellular fractions. Biological systems studied include hepatocytes, human tumor cells, renal proximal tubular cells, cardiomyocytes and isolated mitochondria.




Anticancer drugs

Anticancer drugs conferences 2011 2013                                        Powered by